Artificial intelligence (AI) helped clinicians to accelerate the design of diabetes prevention software, a new study finds.

Publishing online March 6 in the Journal of Medical Internet Research, the study examined the capabilities of a form of artificial intelligence called generative AI or GenAI, which predicts likely options for the next word in any sentence based on how billions of people used words in context on the internet.

Liverpool Heart and Chest Hospital NHS Foundation Trust (LHCH) is honoured to join an elite group of hospitals around the world who have successfully validated against the HIMSS (Healthcare Information and Management Systems Society) international EMRAM Stage 7 standards.

EMRAM - the Electronic Medical Record Adoption Model - assesses a health facility's adoption and maturity of its digital capabilities.

Clinicians in Scotland have easy access to clinical guidelines and validated decision support tools using the Right Decision Service (RDS), built on technology developed by Tactuum.

The RDS is a once-for-Scotland national project funded by the Scottish Government and run by Healthcare Improvement Scotland.

Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.

A Cancer Research UK-funded study reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different subtypes termed evotypes.

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year - nearly a third of all health care spending - on treating preventable diseases like diabetes.

For the 98 million adults who are prediabetic and at risk of developing Type II diabetes, preventive treatments such as the drug metformin can help stave off the disease.

A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

The provocative study, published February 22, in JAMA Ophthalmology, suggests that advanced AI tools, which are trained on vast amounts of data, text, and images,